Jones Financial Companies Lllp Has $102,000 Stake in Fresenius Medical Care AG (NYSE:FMS)

Jones Financial Companies Lllp grew its position in Fresenius Medical Care AG (NYSE:FMS) by 80.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 4,510 shares of the company’s stock after purchasing an additional 2,012 shares during the period. Jones Financial Companies Lllp’s holdings in Fresenius Medical Care were worth $102,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in FMS. Smartleaf Asset Management LLC boosted its stake in shares of Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock valued at $28,000 after buying an additional 806 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in shares of Fresenius Medical Care in the third quarter valued at approximately $38,000. Venturi Wealth Management LLC boosted its stake in shares of Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company’s stock valued at $129,000 after buying an additional 441 shares during the period. GAMMA Investing LLC boosted its stake in shares of Fresenius Medical Care by 43.3% in the fourth quarter. GAMMA Investing LLC now owns 7,164 shares of the company’s stock valued at $162,000 after buying an additional 2,166 shares during the period. Finally, Arbor Investment Advisors LLC bought a new stake in shares of Fresenius Medical Care in the fourth quarter valued at approximately $200,000. Institutional investors and hedge funds own 8.37% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on FMS. StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th. Truist Financial upped their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Finally, Bank of America upgraded Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research note on Monday, December 2nd.

Fresenius Medical Care Stock Up 3.7 %

NYSE FMS opened at $24.04 on Monday. The business has a fifty day moving average price of $23.67 and a two-hundred day moving average price of $22.21. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. Fresenius Medical Care AG has a fifty-two week low of $17.93 and a fifty-two week high of $25.25. The stock has a market capitalization of $14.10 billion, a PE ratio of 19.86, a PEG ratio of 0.76 and a beta of 0.99.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.